CORONA VIRUS INFECTION

This study tested a COVID-19 vaccine called CoviVac to see how well it works and how safe it is for people aged 60 and older. Researchers gave the vaccine to 200 volunteers and checked their immune response and any side effects. The main goal was to see if the vaccine triggers a …

This early-stage study tested three new COVID-19 RNA vaccine candidates in 72 healthy adults. It aimed to check their safety and how well they trigger an immune response in people who have never been vaccinated and in those who received previous COVID vaccines. Participants recei…

This early-stage study tested an experimental drug designed to calm the dangerous overactive immune response (hyperinflammation) seen in severe COVID-19. It involved 68 adults hospitalized with severe COVID-19 who were given the drug or a placebo. The main goal was to see if the …

This completed early-stage study tested whether an experimental drug called SIR1-365 is safe for hospitalized patients with severe COVID-19. Researchers enrolled 45 adults to receive either the drug or a placebo for 14 days, monitoring side effects and whether it helped reduce in…

This study tested whether the drug sarilumab could help hospitalized adults with severe COVID-19. Sarilumab targets inflammation, which can cause serious lung problems. The trial compared the drug to a placebo in 420 patients to see if it improved recovery, reduced the need for b…

This study aimed to check how well different blood tests could detect COVID-19 antibodies. Researchers collected samples from 101 people, including COVID-19 patients and healthcare workers, to compare several commercial tests. The goal was to determine which tests were most accur…

This study created a registry to understand how COVID-19 affects the kidneys. It tracked 500 patients with confirmed COVID-19 to see how often kidney injury occurred, who was most at risk, and what the outcomes were. The goal was to gather information to help guide future treatme…

This study aimed to understand how people with lung cancer develop and maintain immunity after getting COVID-19 or receiving a COVID-19 vaccine. Researchers observed nearly 2,000 patients across Spain, checking their blood for protective antibodies at different times. The goal wa…

This study observed over 1,000 adults with severe COVID-19 who were treated in French intensive care units (ICUs). The goal was to document exactly how these critically ill patients were cared for and to identify which treatments and patient factors were linked to better or worse…

This study followed 211 older adults who were hospitalized with COVID-19 to understand how they recover their mobility and daily function over time. Researchers tracked participants' physical abilities, breathing, and overall health after leaving the hospital. The goal was to gat…

This study aimed to understand how the body's immune system, specifically T-cells, responds to COVID-19 during and after infection. Researchers measured T-cell activity and antibody levels in 51 hospitalized COVID-19 patients and healthy hospital staff. The goal was to learn how …